UY29115A1 - Un procedimiento para fabricar compuestos enantiomericos del imidazol - Google Patents

Un procedimiento para fabricar compuestos enantiomericos del imidazol

Info

Publication number
UY29115A1
UY29115A1 UY29115A UY29115A UY29115A1 UY 29115 A1 UY29115 A1 UY 29115A1 UY 29115 A UY29115 A UY 29115A UY 29115 A UY29115 A UY 29115A UY 29115 A1 UY29115 A1 UY 29115A1
Authority
UY
Uruguay
Prior art keywords
imidazol
procedure
manufacturing
enantiomeric compounds
sertaconazole mononitrate
Prior art date
Application number
UY29115A
Other languages
English (en)
Spanish (es)
Inventor
Ines Petschen
Xavier Camps
Juan Sallares
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35614444&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29115(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of UY29115A1 publication Critical patent/UY29115A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
UY29115A 2004-09-13 2005-09-13 Un procedimiento para fabricar compuestos enantiomericos del imidazol UY29115A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200402184A ES2249992B1 (es) 2004-09-13 2004-09-13 Un procedimiento para fabricar compuestos enantiomericos del imidazol.

Publications (1)

Publication Number Publication Date
UY29115A1 true UY29115A1 (es) 2005-11-30

Family

ID=35614444

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29115A UY29115A1 (es) 2004-09-13 2005-09-13 Un procedimiento para fabricar compuestos enantiomericos del imidazol

Country Status (23)

Country Link
US (1) US7626038B2 (cg-RX-API-DMAC7.html)
EP (1) EP1794152B1 (cg-RX-API-DMAC7.html)
JP (1) JP5048500B2 (cg-RX-API-DMAC7.html)
KR (1) KR100903922B1 (cg-RX-API-DMAC7.html)
CN (1) CN101023077B (cg-RX-API-DMAC7.html)
AR (1) AR050931A1 (cg-RX-API-DMAC7.html)
AT (1) ATE402171T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005284330B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0515259A (cg-RX-API-DMAC7.html)
CA (1) CA2577247C (cg-RX-API-DMAC7.html)
DE (1) DE602005008454D1 (cg-RX-API-DMAC7.html)
DK (1) DK1794152T3 (cg-RX-API-DMAC7.html)
ES (1) ES2249992B1 (cg-RX-API-DMAC7.html)
MX (1) MX2007002939A (cg-RX-API-DMAC7.html)
NO (1) NO20071817L (cg-RX-API-DMAC7.html)
PA (1) PA8645501A1 (cg-RX-API-DMAC7.html)
PE (1) PE20060720A1 (cg-RX-API-DMAC7.html)
PL (1) PL1794152T3 (cg-RX-API-DMAC7.html)
PT (1) PT1794152E (cg-RX-API-DMAC7.html)
RU (1) RU2413728C2 (cg-RX-API-DMAC7.html)
TW (1) TWI405760B (cg-RX-API-DMAC7.html)
UY (1) UY29115A1 (cg-RX-API-DMAC7.html)
WO (1) WO2006029811A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8635593B2 (en) * 2008-05-13 2014-01-21 Hewlett-Packard Development Company, L.P. Dynamic autocompletion tool
CN112595803A (zh) * 2020-12-31 2021-04-02 海南海神同洲制药有限公司 一种硝酸舍他康唑乳膏的鉴别方法
CN113501814A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑的纯化方法
CN113480517B (zh) * 2021-07-30 2022-09-09 海南海神同洲制药有限公司 3-溴甲基-7-氯苯并[b]噻吩的合成方法
CN113501815A (zh) * 2021-07-30 2021-10-15 海南海神同洲制药有限公司 一种硝酸舍他康唑晶型的制备方法
CN113816947A (zh) * 2021-08-25 2021-12-21 海南海神同洲制药有限公司 一种硝酸舍他康唑的重结晶方法
CN113735843B (zh) * 2021-09-07 2023-05-26 海南海神同洲制药有限公司 一种低熔点硝酸舍他康唑的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1096361B (it) 1978-05-18 1985-08-26 Recordati Chem Pharm Dibenzileteri sostituiti terapeuticamente attivi
JPS57169466A (en) 1981-04-14 1982-10-19 Ota Seiyaku Kk Preparation of imidazole derivative
ES8504779A1 (es) * 1984-02-02 1985-05-01 Ferrer Int Procedimiento de obtencion de nuevos derivados de 1h-imidazol
US5135943A (en) * 1984-02-02 1992-08-04 Ferrer Internacional S.A. 1H-imidazole derivative compounds and pharmaceutical compositions containing the same
CA1250586A (en) 1984-02-02 1989-02-28 Manuel Raga 1h-imidazole derivatives and process for their production
JP3250809B2 (ja) * 1995-01-04 2002-01-28 フエルレル インターナショナル,ソシエダッド アノニマ 1−[2,4−ジクロロ−β−[(7−クロロベンゾ[b]チエニ−3−イル)メトキシ]フェネチル]イミダゾール・1硝酸塩の同質異像B及びC
CZ20012338A3 (cs) * 1998-12-24 2001-12-12 Fujisawa Pharmaceutical Co., Ltd. Imidazolové sloučeniny
CN1191250C (zh) * 2001-09-26 2005-03-02 河北省药物研究所 一种硝酸舍他康唑的合成方法
ES2203316B1 (es) * 2002-02-11 2005-03-01 Ferrer Internacional, S.A. R-(-)-1-(2-(7-cloro-benzo(b)tiofen-3-il-metoxi)-2-(2,4-dicloro-fenil)-etil)1h-imidazol.

Also Published As

Publication number Publication date
TW200621756A (en) 2006-07-01
PL1794152T3 (pl) 2008-12-31
US20080108682A1 (en) 2008-05-08
KR20070042206A (ko) 2007-04-20
RU2007113921A (ru) 2008-10-20
JP5048500B2 (ja) 2012-10-17
TWI405760B (zh) 2013-08-21
KR100903922B1 (ko) 2009-06-19
PT1794152E (pt) 2008-10-24
ATE402171T1 (de) 2008-08-15
AR050931A1 (es) 2006-12-06
ES2249992B1 (es) 2007-03-01
US7626038B2 (en) 2009-12-01
WO2006029811A1 (en) 2006-03-23
DK1794152T3 (da) 2008-11-17
RU2413728C2 (ru) 2011-03-10
EP1794152A1 (en) 2007-06-13
MX2007002939A (es) 2007-04-27
CA2577247A1 (en) 2006-03-23
NO20071817L (no) 2007-05-16
EP1794152B1 (en) 2008-07-23
PA8645501A1 (es) 2006-05-16
BRPI0515259A (pt) 2008-07-15
HK1105416A1 (en) 2008-02-15
JP2008512421A (ja) 2008-04-24
CA2577247C (en) 2011-07-05
DE602005008454D1 (de) 2008-09-04
CN101023077A (zh) 2007-08-22
PE20060720A1 (es) 2006-07-11
AU2005284330A1 (en) 2006-03-23
CN101023077B (zh) 2012-05-23
AU2005284330B2 (en) 2011-01-06
ES2249992A1 (es) 2006-04-01

Similar Documents

Publication Publication Date Title
Borisa et al. A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
CR10125A (es) Compuestos de azaindol inhibidores de aurora quinasas
EG25300A (en) Process for the manufacture of 1,2-dichloroethane.
TW200740435A (en) Therapeutic agent for diabetes
EG25281A (en) Process for the manufacture of 1,2-dichloroethane.
NO2012017I1 (no) Benzimidazolderivat, fremgangsmåte for fremstilling derav, medikament inneholdende denne forbindelsen samt anvendelse av forbindelsen.
ECSP105178A (es) Compuestos de aril urea en combinación con otros agentes citostáticos o citotóxicos para el tratamiento de cáncer en humanos
DE502004002801D1 (de) Bohrlochbehandlungsmittel, enthaltend ethercarbonsäuren
AR094376A2 (es) Proceso de producción de un compuesto orgánico
CL2013002617A1 (es) Proceso para preparar una composicion de inhibidores de jak(pirrolo(2,3-d)pirimidin-4-il)pirazolil-3-ciclopentilpropanonitrilo tratando un exceso enantiometrico r o s mediante una reaccion de epimerizacion en presencia de base o una retro adicion de michael.
WO2009001060A3 (en) Use of compounds for preparing anti-tuberculosis agents
WO2006113703A3 (en) Carboline derivatives useful in the treatment of cancer
CL2011000739A1 (es) Un compuesto 3,5-bis(3,4-dihidroxifenil)-1,2,4-triazol; composición farmacéutica que lo comprende, útil para el tratamiento de enfermedades causadas por un beta-amiloide o una sinucleinopatia, tal como enfermedad de alzheimer y enfermedad de parkinson.
HN2000000266A (es) Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
WO2009016149A3 (en) Process for manufacturing glycidol
PE20180504A1 (es) PROCESOS E INTERMEDIARIOS PARA LA PREPARACION DE {1-(ETILSULFONIL)-3-[4-(7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL)-1H-PIRAZOL-1-IL]AZETIDIN-3-IL}ACETONITRILO
BRPI0408922B1 (pt) processo para o tratamento termomecánico de aço.
PT2056805E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular
CR11605A (es) Tratamiento de plantas ornamentales
WO2004048534A3 (en) Modulation of cytokine-inducible kinase expression
NL1026203A1 (nl) Verbindingen toepasbaar voor de behandeling van ziekten.
CO2024004227A2 (es) Métodos y composiciones para el tratamiento de la enfermedad renal poliquística
WO2006089871A3 (en) Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
WO2005089515A3 (en) Methods for the treatment of synucleinopathies
NL1028599A1 (nl) Verbindingen voor de behandeling van ziekten.